| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Karsten Muenstedt | |
| Samer El-Safadi | |||
| P2860 | cites work | Mega-dose vitamins and minerals in the treatment of non-metastatic breast cancer: an historical cohort study | Q44229616 |
| Diet and breast cancer: evidence that extremes in diet are associated with poor survival | Q44493459 | ||
| Selenium levels during the course of radiotherapy. No influence of irradiation on blood selenium concentration. | Q51676720 | ||
| Multivitamins do not improve radiation therapy-related fatigue: results of a double-blind randomized crossover trial. | Q53178709 | ||
| Folate and Risk of Breast Cancer: A Meta-analysis | Q58497175 | ||
| Prognostic Effects of 25-Hydroxyvitamin D Levels in Early Breast Cancer | Q60595420 | ||
| Ascorbic acid (vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro | Q71089222 | ||
| The role of vitamin E in the prevention of cancer: a meta-analysis of randomized controlled trials | Q80146179 | ||
| Intake of vitamin D and risk of breast cancer--a meta-analysis | Q81553551 | ||
| U-shaped dose-response curves: implications for risk characterization of essential elements and other chemicals | Q82528203 | ||
| Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases | Q24242944 | ||
| Effect of selenium in combination with Adriamycin or Taxol on several different cancer cells | Q28142742 | ||
| Vitamin D and calcium: a systematic review of health outcomes. | Q34023107 | ||
| Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, part 1. | Q34574920 | ||
| An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day. | Q34575621 | ||
| Ingestion of selenium and other antioxidants during prostate cancer radiotherapy: a good thing? | Q34615803 | ||
| Prevalence of micronutrient malnutrition worldwide | Q34660272 | ||
| Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized controlled trials | Q34795525 | ||
| Pros and cons of antioxidant use during radiation therapy | Q34894505 | ||
| Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials | Q35010512 | ||
| Antioxidants and cancer therapy: a systematic review | Q35643086 | ||
| Dietary antioxidants and human cancer | Q35937796 | ||
| Trace elements and cancer risk: a review of the epidemiologic evidence | Q36691257 | ||
| Multivitamin-multimineral supplements: who uses them? | Q36701918 | ||
| Antioxidants and other nutrients do not interfere with chemotherapy or radiation therapy and can increase kill and increase survival, Part 2. | Q36779055 | ||
| Use of antioxidant supplements during breast cancer treatment: a comprehensive review | Q37288620 | ||
| Vitamin D, aging, and cancer | Q37290271 | ||
| Serum selenium and peripheral arterial disease: results from the national health and nutrition examination survey, 2003-2004 | Q37306063 | ||
| Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells | Q39940011 | ||
| Serum antioxidants and skin cancer risk: an 8-year community-based follow-up study | Q42451656 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 383-387 | |
| P577 | publication date | 2010-12-08 | |
| P1433 | published in | Breast Care | Q15764648 |
| P1476 | title | Nutritive Supplements - Help or Harm for Breast Cancer Patients? | |
| P478 | volume | 5 |
| Q36162969 | 25-Hydroxyvitamin D and TSH as Risk Factors or Prognostic Markers in Thyroid Carcinoma | cites work | P2860 |
Search more.